Evidence map›Paper›PMID 38678559›Full record

ArticleCell reports2024

Selective targeting of mu opioid receptors to primary cilia.

Rita R Fagan, David F Lee, Matan Geron, Grégory Scherrer, Mark von Zastrow, Aliza T Ehrlich

Abstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. The nociceptor primary cilium.Brain : a journal of neurology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Identification of New Ciliary Signaling Pathways in the Brain and Insights into Neurological Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  12. Review
  13. Pain Signaling by GPCRs and RTKs.Trends in pharmacological sciences · 2025
    Review
  14. Convergence of autism proteins at the cilium.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
  17. The Nociceptor Primary Cilium Contributes to Mechanical Nociceptive Threshold and Inflammatory and Neuropathic Pain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rita R FaganDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94158, USA.
David F LeeDepartment of Cell Biology and Physiology, UNC Neuroscience Center, Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Matan GeronDepartment of Cell Biology and Physiology, UNC Neuroscience Center, Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Grégory ScherrerDepartment of Cell Biology and Physiology, UNC Neuroscience Center, Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; New York Stem Cell Foundation, Chapel Hill, NC 27599, USA.
Mark von ZastrowDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: mark.vonzastrow@ucsf.edu.
Aliza T EhrlichDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: aliza.ehrlich@ucsf.edu.

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alan Ashworth · 1999 to 2026
$209.7M
PROTEINS REGULATING ENDOCYTOSIS OF OPIOID RECEPTORSR01DA012864 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mark E Von Zastrow · 2000 to 2026
$7.9M
Membrane Trafficking of Opioid and Adrenergic ReceptorsR01DA010711 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 2014 to 2023
$4.6M
GPR88 localization to primary cilia and its impact on striatal cAMP signalingR01MH120212 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 2019 to 2023
$2.0M
Identification of cells and signaling mechanisms underlying opioid analgesia and side effectsR01DA044481 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SCHERRER, GREGORY · 2017 to 2021
$1.8M
Neuronal Gαi-GPCR targeting to primary cilia and impact on cAMP mediated transcriptionK01MH123757 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EHRLICH, ALIZA TOBY · 2020 to 2024
$792k
Investigating the trafficking mechanisms and signaling consequences of dopamine receptor primary cilia localizationF32MH130096 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FAGAN, RITA REALE · 2022 to 2024
$213k
NCI NIH HHS P30 CA082103NIDA NIH HHS R01 DA010711NIDA NIH HHS R01 DA012864NIDA NIH HHS R01 DA044481NIMH NIH HHS F32 MH130096NIMH NIH HHS K01 MH123757NIMH NIH HHS R01 MH120212
6 · The paper itself

Abstract

Opioid receptors are therapeutically important G protein-coupled receptors (GPCRs) with diverse neuromodulatory effects. The functional consequences of opioid receptor activation are known to depend on receptor location in the plasma membrane, but mechanisms mediating selective localization of receptors to any particular membrane domain remain elusive. Here, we demonstrate the targeting of the mu opioid receptor (MOR) to the primary cilium, a discrete microdomain of the somatic plasma membrane, both in vivo and in cultured cells. We further show that ciliary targeting is specific to MORs, requires a 17-residue sequence unique to the MOR cytoplasmic tail, and additionally requires the Tubby-like protein 3 (TULP3) ciliary adaptor protein. Our results reveal the potential for opioid receptors to undergo selective localization to the primary cilium. We propose that ciliary targeting is mediated through an elaboration of the recycling pathway, directed by a specific C-terminal recycling sequence in cis and requiring TULP3 in trans.

Indexed as

CiliaReceptors, Opioid, muAnimalsHEK293 CellsHumansMiceProtein TransportReceptors, Opioid, mubrainCP: Cell biologyG protein-coupled receptorMORmouseneuronalprimary ciliumrecyclingTULP3

Identifiers

PMID38678559
PMCPMC11257377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.